WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009137493) 2-SUBSTITUTED BENZOFURAN COMPOUNDS TO TREAT INFECTION WITH HEPATITIS C VIRUS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/137493    International Application No.:    PCT/US2009/042861
Publication Date: 12.11.2009 International Filing Date: 05.05.2009
IPC:
A61K 31/343 (2006.01), C07D 307/80 (2006.01), A61P 31/00 (2006.01)
Applicants: WYETH [US/US]; Five Giralda Farms Madison, NJ 07940 (US) (For All Designated States Except US).
VIROPHARMA INCORPORATED [US/US]; 730 Stockton Drive Exton, PA 19341 (US) (For All Designated States Except US).
BLOOM, Jonathan, D. [US/US]; (US) (For US Only).
LEVIN, Jeremy [US/US]; (US) (For US Only).
ZAPF, Christoph [DE/US]; (US) (For US Only)
Inventors: BLOOM, Jonathan, D.; (US).
LEVIN, Jeremy; (US).
ZAPF, Christoph; (US)
Agent: MOLENDA, Victoria, S.; (US)
Priority Data:
61/050,301 05.05.2008 US
Title (EN) 2-SUBSTITUTED BENZOFURAN COMPOUNDS TO TREAT INFECTION WITH HEPATITIS C VIRUS
(FR) COMPOSÉS BENZOFURANE SUBSTITUÉS EN POSITION 2 POUR TRAITER UNE INFECTION PAR LE VIRUS DE L'HÉPATITE C
Abstract: front page image
(EN)Compounds of formula (I) wherein R1, R2, R3, R4, R5, and R6 are as defined herein, including all crystalline forms and pharmaceutically acceptable salts thereof, which are useful in pharmaceutical formulations for the treatment or prevention of hepatitis C virus infections and diseases associated with such infections.
(FR)L'invention concerne des composés de formule (I), dans laquelle R1, R2, R3, R4, R5, et R6 sont tels que définis ici. L'invention concerne notamment toutes les formes cristallines et les sels pharmaceutiquement acceptables des composés, qui sont utiles dans des formulations pharmaceutiques pour le traitement ou la prévention d'infections par le virus de l'hépatite C et de maladies associées à ces infections.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)